Email This Article
Genzyme Warns on Lower Renagel Sales
By
Adam Feuerstein
03/27/02 - 09:46 AM EST
The biotech says sales of dialysis drug will be down as part of an inventory reduction.
The information entered on this page will not be used to send unsolicited email and will not be sold to a 3rd party.
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,231.70 | 1,091.23 | 2,157.47 | 35.17 |
Oil *
75.87
|
|
DOWN
59.56
|
DOWN
7.28
|
DOWN
9.43
|
UP
0.43
|
10 Yr
3.52%
SPDR Gold
108.42
|
|
-0.58%
|
-0.66%
|
-0.44%
|
+1.24%
|
Data delayed 20 minutes |


Connect with TheStreet